AHR and Miyoshi myopathy: They demonstrated that Clofazamine (CLF), a drug that has been shown to have AhR antagonizing activity, induced cytotoxicity in MM cell lines, slowed MM xenograft growth, and moderately reduced disease burden in vivo by measuring serum IgG.